Apellis Pharmaceuticals Inc (APLS)
NASDAQ:APLS
Holding APLS?
Track your performance easily

Apellis Pharmaceuticals (APLS) Financial Statements

848 Followers

Apellis Pharmaceuticals Financial Overview

Apellis Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.037; its P/E ratio is -14.72; Apellis Pharmaceuticals is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-0.38. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 196.83M$ 199.69M$ 172.32M$ 146.38M$ 110.40M
Gross Profit$ 196.83M$ 199.69M$ 172.32M$ 118.66M$ 110.40M
EBIT$ -56.85M$ -37.54M$ -39.08M$ -79.75M$ -140.00M
EBITDA$ -55.74M$ -36.86M$ -38.56M$ -79.26M$ -139.47M
Net Income Common Stockholders$ -57.45M$ -37.66M$ -66.42M$ -88.58M$ -140.24M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 396.90M$ 360.10M$ 325.90M$ 351.20M$ 452.40M
Total Assets$ 901.87M$ 904.48M$ 831.93M$ 788.73M$ 818.22M
Total Debt$ 470.45M$ 474.51M$ 109.14M$ 110.93M$ 109.58M
Net Debt$ 73.55M$ 114.41M$ -216.76M$ -240.27M$ -342.82M
Total Liabilities$ 664.75M$ 640.15M$ 565.25M$ 594.21M$ 585.95M
Stockholders Equity$ 237.12M$ 305.89M$ 266.68M$ 194.52M$ 232.27M
Cash Flow-
Free Cash Flow$ 34.10M$ -8.43M$ -133.28M$ -97.97M$ -169.13M
Operating Cash Flow$ 34.10M$ -8.34M$ -132.98M$ -97.88M$ -169.09M
Investing Cash Flow-$ -90.00K$ -293.00K$ 4.00K$ -47.00K
Financing Cash Flow$ 2.54M$ 42.49M$ 108.21M$ -3.91M$ 5.75M
Currency in USD

Apellis Pharmaceuticals Earnings and Revenue History

Apellis Pharmaceuticals Debt to Assets

Apellis Pharmaceuticals Cash Flow

Apellis Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis